Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 19 clinical trials
The Efficacy of the 7 Days Tailored Therapy as the 1st Eradication of H. Pylori Infection

To compare the eradication success rate between 10-days sequential therapy and 7-days tailored therapy based on H. pylori culture and antimicrobial susceptibility testing.

  • 4 views
  • 31 Mar, 2021
  • 1 location
Steroids and Cross-linking for Ulcer Treatment

participate will be randomized to one of three treatment groups: Group 1: Standard therapy, topical 0.5% moxifloxacin plus topical placebo plus sham CXL Group 2: Early steroids, topical 0.5

  • 0 views
  • 09 Dec, 2021
  • 4 locations
The Efficacy of the 7 Days Tailored Therapy as 2nd Rescue Therapy for Eradication of H. Pylori Infection

As increasing the antibiotics resistance, the effectiveness of traditional Helicobacter pylori (H. pylori) therapies has been declined coincidentally. In this study, the investigators evaluated the efficacy of H. pylori eradication between a 7 days personalized therapy for H. pylori infection based on the results of antibiotics resistance by using H. …

  • 21 views
  • 31 Mar, 2021
  • 1 location
Refining MDR-TB Treatment (T) Regimens (R) for Ultra(U) Short(S) Therapy(T)

The purpose of this study is to assess the efficacy, safety and tolerability of a combination of levofloxacin, linezolid, cycloserine and pyrazinamide (or clofazimine if resistant to pyrazinamide) treatments for 24 to 32 weeks (regimen consisted of clofazimine for 36~44 weeks) in subjects with multidrug-resistant tuberculosis (MDR-TB) compared to WHO …

rifampin
levofloxacin
smear
pulmonary tuberculosis
clofazimine
  • 0 views
  • 24 Jan, 2021
  • 13 locations
Dropless Pars Plana Vitrectomy Study (DVS)

To demonstrate that intraoperative use of subtenon triamcinolone acetonide at the time of surgery without postoperative eye drops is non-inferior to the regimen of postoperative eye drops following primary pars plana vitrectomy for retinal detachment.

Accepts healthy volunteers
  • 0 views
  • 12 Aug, 2022
  • 1 location
Patient-reported Experiences and Quality of Life Outcomes in the TB-PRACTECAL Clinical Trial

PRACTECAL-PRO is a sub-study of a TB-PRACTECAL clinical trial for multidrug resistant Tuberculosis. It evaluates the effectiveness of TB-PRACTECAL interventions from the patient perspective in terms of their quality of life, shared decision making and satisfaction with services.

moxifloxacin
clofazimine
pretomanid
bedaquiline
linezolid
  • 2 views
  • 24 May, 2021
  • 7 locations
Lefamulin for M. Genitalium Treatment Failures

The purpose of this drug study is to find out whether the antibiotic lefamulin (trade name Xenleta) will cure Mycoplasma genitalium infections that have not been cured by prior antibiotics while finding out whether it is more effective if the antibiotic doxycycline is taken first.

  • 0 views
  • 11 May, 2022
  • 1 location
Ranibizumab Vs Bevacizumab for Type 1 Retinopathy of Prematurity

Retinopathy of prematurity (ROP) with inadequate growth and development of retinal blood vessels in premature infants is one of the foremost reasons for childhood blindness. Recently there is a shift of treatment to VEGF inhibitors which can regress ROP without destroying the peripheral retina. Yet, the best drug has not …

  • 0 views
  • 09 Sep, 2021
  • 1 location
Moxifloxacin in Adjuvant Treatment of Patients With Operable Breast Cancer

moxifloxacin or placebo.

ductal carcinoma
docetaxel
doxorubicin
cyclophosphamide
carcinoma
  • 0 views
  • 22 Nov, 2021
  • 1 location
Omadacycline vs. Moxifloxacin for the Treatment of Community-Acquired Bacterial Pneumonia

The purpose of this study is to evaluate the safety and efficacy of omadacycline as compared to moxifloxacin in the treatment of adults with community-acquired bacterial pneumonia.

  • 0 views
  • 09 Jun, 2022
  • 18 locations